Cognizant Technology Solutions gets a prior buy rating from 2023 reaffirmed, somewhat more bullish than the consensus today. Its upside is driven by revenue growth forecasts, strong margins ...

Morgan Stanley lowered the firm’s price target on Cognizant (CTSH) to $80 from $85 and keeps an Equal Weight rating on the shares. The firm ...

Cognizant Technology Solutions Corporation Price and Consensus Cognizant Technology Solutions Corporation price-consensus-chart | Cognizant ... year over year. This growth was driven by improving ...

According to The Wall Street Journal, activist investor Mantle Ridge has built a $1 billion+ stake in Cognizant Technology Solutions (CTSH), ...

While we anticipate some benefit to top-line growth from this demand, competition from incumbents like Accenture who have stronger consulting businesses will likely strain Cognizant’s market ...

Looking ahead to fiscal year 2025 (FY25), Cognizant has provided initial guidance that suggests moderate growth. The company anticipates revenues of $20.66 billion and adjusted EPS of $4.98.

Cognizant Technology Solutions Corporation Price and Consensus Cognizant Technology Solutions Corporation price-consensus-chart | Cognizant ... reflects solid top-line growth potential over ...

Cognizant’s comprehensive service suite for health sciences clients, including patient engagement platforms and AI-driven claims processing, boosted growth. Products and Resources revenues (25.5 ...

Cognizant (NASDAQ: CTSH), today announced that it has received the 2025 World's Most Ethical Companies® recognition by Ethisphere, a global leader in defining and advancing the standards of ethical ...

Cognizant Technology Solutions Corporation (NASDAQ:CTSH), a leading provider of information technology, consulting, and business process outsourcing services, has been demonstrating resilience and ...